Trump Appointees Accused of Chemical Safety Board Bias

The Trump administration has appointed scientists with significant financial conflicts of interest to the Environmental Protection Agency's (EPA) Science Advisory Committee on Chemicals (SACC), according to public health advocates. These appointees are alleged to have industry ties and stand to benefit from deregulation, raising concerns about the integrity of the board's reviews of toxic chemical research. The SACC is responsible for evaluating scientific data on numerous hazardous substances.

A coalition of public health advocacy groups has filed comments with the EPA, asserting that at least 13 proposed Trump appointees are likely conflicted on the chemicals they will be tasked with reviewing. This potential bias could lead the committee to provide justification for regulatory rollbacks, undermining public health protections. The advocates warn that the panel may prioritize industry interests over scientific evidence and public safety.

The appointments are particularly concerning given the SACC's role in reviewing research for dozens of toxic chemicals. The committee's findings can influence EPA decisions on chemical safety regulations, including restrictions on their use or production. Critics argue that the selection process has prioritized individuals with a history of supporting industry positions rather than those with an unbiased commitment to public health and environmental science.

These allegations suggest a pattern of prioritizing deregulation and industry interests within the administration's environmental policy. The potential for conflicted scientists to influence the review of toxic chemicals poses a significant risk to communities exposed to these substances. Public health organizations are calling for greater transparency and accountability in the appointment process for scientific advisory boards.